Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 809-811

  Vermot, D ^a   Entenza, J M ^a   Vouillamoz, J ^a   Glauser, M P ^a   Moreillon, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN;

ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; AORTA VALVE; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SANGUINIS;

EID: 0030071464     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.809     Document Type: Article

References (19)

1. Bayer, A. S., and J. Tu. 1990 Chemoprophylactic efficacy against experimental endocarditis caused by β-lactamase-producing. aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity. Aritimicrob. Agents Chemother. 34:1068-1074
2. Chu, S. Y., Y. Park, C. Locke, D. S. Wilson, and J. C. Cavanaugh. 1992. Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial. J. Clin. Pharmacol. 32:32-36
3. Dajani, A. S., A. L. Bisno, K. J. Chung, D. T. Durack, M. Freed, M. A. Gerber, A. W. Karchmer, H. D. Millard, S. Rahimtoola, S. T. Shulman, C. Watanakunakorn, and K. A. Taubert. 1990. Prevention of bacterial endocarditis Recommendations by the American Heart Association. JAMA 264: 2919-2922
4. Endocarditis Working Party of the British Society for Antimicrobial Chemotherapy. 1990. Antibiotic prophylaxis of infective endocarditis. Lancet 335:88-89.
5. Entenza, J. M., M. Blatter, M. P. Glauser, and P. Moreillon. 1994. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci Antimicrob. Agents Chemother. 38:2683-2688.
6. Fluckiger, U., P. Francioli, J. Blaser, M. P. Glauser, and P. Moreillon. 1994 Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci J. Infect. Dis. 169:1397-1400.
7. Gatti, G., J. Flaherty, J. Bubp, J. White, M. Borin, and J. Gambertoglio. 1993. Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS Antimicrob Agents Chemother. 37:1137-1143.
8. Glauser, M. P., J. P. Bernard, P. Moreillon, and P. Francioli. 1983. Successful single dose amoxicillin prophylaxis against experimental endocarditis: evidence for two mechanisms of protection. J. Infect. Dis 147:568-575.
9. Hall, G., S. A. Hedstrom, A. Heimdabl, and C. E. Nord. 1993. Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin. Infect. Dis. 17:188-194
10. Heraief, E., M. P. Glauser, and L. Freedman. 1982. Natural history of aoitic valve endocarditis in rats. Infect. Immun. 37:127-131.
11. Lode, H., M. Boeckh, T. Schaberg, K. Borner, and P. Koeppe. 1993. Pharmacology p. 61-67. In H. C. Neu, L. S. Young, and S. H. Zimmer (ed.), The new macrolides, azalides and streptogramins. Pharmacology and clinical applications. Marcel Dekker, Inc., New York.
12. Moreillon. P., P. Francioli, D. Overholser, P. Meylan. and M. P. Glauser. 1986. Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius. J Infect Das. 154:801-807.
13. Moreillon, P., C. D. Overholser, R. Malinverni, J. Bille, and M. P. Glauser. 1988. Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease. J. Infect. Dis. 157:990-995.
14. Sabath, L. D., N. Wheeler, M. Laverdiere, D. Blazevic, and B. J. Wilkinson. 1977. A new type of penicillin resistance of Staphylococcus aureus. Lancet i:443-447.
15. Sahm, D. F., and J. A.Washington II. 1991. Antibacterial susceptibility tests, dilution methods, p. 1105-1116. In E. Balows. W. J. Hausler, K. L. Herrmann, H. D. Isenberg. and H. J. Shadomy (ed.). Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
16. Schweizerische Arbeitsgruppe für Endokarditisprophylaxe. 1984. Empfehlungen der Schweizerischen Arbeitsgruppe fur Endokarditisprophylaxe. Prophylaxe der bakteriellen Endokarditis. Schweiz. Med. Wochenschr. 114:1246-1252.
17. Simmons, N. A. 1993 Recommendations for endocarditis prophylaxis. J. Antimicrob. Chemother. 31:437-438.
18. Steigbigel, N. H. 1990 Erythromycin, lincomycin, and clindamycin, p. 308-317. In G L Mandell, R. G Douglas, and J. E. Bennett (ed.). Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York.
19. Swartzberg, J. E., R. M. Maresca, and J. S. Remington. 1976. Gastrointestinal side effects associated with clindamycin. Arch Intern. Med. 136:876-879.